Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure.
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001688:Biological Products / Q000627:therapeutic use; D001706:Biopsy; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D001997:Bronchopulmonary Dysplasia / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D002110:Caffeine / Q000627:therapeutic use; D002585:Cesarean Section; D002951:Citrates / Q000627:therapeutic use; D003131:Combined Modality Therapy; D045422:Continuous Positive Airway Pressure / Q000295:instrumentation / Q000379:methods*; D004195:Disease Models, Animal; D004338:Drug Combinations; D005240:Feasibility Studies; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000379:methods; D008168:Lung / Q000254:growth & development; D010215:Papio; D010289:Parenteral Nutrition, Total / Q000379:methods; D010743:Phospholipids / Q000627:therapeutic use; D011659:Pulmonary Gas Exchange; D012307:Risk Factors; D013997:Time Factors; D015300:Ventilator Weaning / Q000379:methods
D001688:Biological Products; D002951:Citrates; D004338:Drug Combinations; D010743:Phospholipids; D002110:Caffeine; C068291:poractant alfa; C026189:caffeine citrate